| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Engineering | 7 | 10 | 275 |
2 | Business | 3 | 8 | 224 |
3 | Health Sciences | 2 | 2 | 69 |
4 | Arts | 1 | 5 | 80 |
5 | Language Studies | 1 | 5 | 80 |
Libreville Hospital
×
1K
Publications
12.2K
Citations
| Year | Citations | |
|---|---|---|
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial | 2022 | 626 |
2005 | 215 | |
2011 | 100 | |
2007 | 99 | |
2019 | 98 | |
2011 | 92 | |
2013 | 87 | |
2009 | 85 | |
2008 | 78 | |
2002 | 73 |
Page 1
Page 1